Operator: Greetings, and welcome to the Rain Oncology, Inc. First Quarter 2023 Earnings Call. At this time, all participants are in a listen-only mode.
Operator: Greetings, and welcome to the Rain Therapeutics Third Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.
Rain Therapeutics Inc. (NASDAQ:NASDAQ:RAIN) Q1 2022 Results Conference Call May 04, 2022 05:00 PM ET Company Participants Bob Yedid - LifeSci Advisors Avanish Vellanki - CEO Robert Doebele.